Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions.
Market Dynamics
Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually.
Key features of the study:
This report provides in-depth analysis of the cetirizine hydrochloride market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cetirizine hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market
Detailed Segmentation:
Global Cetirizine Hydrochloride Market, By Dosage Form:
Tablet
Syrup
Solution
Global Cetirizine Hydrochloride Market, By Age Group:
Adult
Pediatric
Global Cetirizine Hydrochloride Market, By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
Global Cetirizine Hydrochloride Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Cetirizine Hydrochloride Market, By Geography:
North America
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Dosage Form:
Tablet
Syrup
Solution
By Age Group:
Adult
Pediatric
By Application:
Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Johnson and Johnson*
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Market Strategies
Mylan, Inc.
Nicox S.A.
Strides Shasun
Apotex, Inc.
Teva UK Limited
Aurobindo Pharma Limited
Jubiliant Life Sciences
Tris Pharma, Inc.
Cipla Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Dosage Form
o Market Snippet, By Age Group
o Market Snippet, By Application
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Market Trends
o Regulatory Scenario
o Impact Analysis
o Key Highlights
o PEST Analysis
o Epidemiology
4. Global Cetirizine Hydrochloride Market, By Dosage Form, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Tablet
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Syrup
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Solution
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
5. Global Cetirizine Hydrochloride Market, By Age Group, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Adult
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Pediatric
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
6. Global Cetirizine Hydrochloride Market, By Application, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Allergic Rhinitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Allergic Conjunctivitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Eczema
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
7. Global Cetirizine Hydrochloride Market, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospital Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
8. Global Cetirizine Hydrochloride Market, By Region, 2016 - 2026, (US$ Mn)
o Introduction
o Market Share Analysis, By Region, 2016 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017-2026
o North America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o U.S.
o Canada
o Latin America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Johnson and Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Mylan, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Nicox S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Strides Shasun
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Apotex, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Teva UK Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Aurobindo Pharma Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Jubiliant Life Sciences
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Tris Pharma, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Cipla Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 28 market data tables and 28 figures on "Cetirizine Hydrochloride Market - Global forecast to 2026".
